HHS Privacy Rule Will Close “Loophole” On Drug Marketing To Patients
Executive Summary
HHS' final privacy regulations will close a loophole that would have allowed pharmaceutical companies to obtain protected patient information from healthcare providers for purposes of marketing products directly to patients
You may also be interested in...
Texas Medical Privacy Law: Rx Industry Seeks Amendment Before Sept. 1
The pharmaceutical industry is attempting to amend a Texas medical privacy law that would restrict drug companies' use of patient information before the law's Sept. 1 compliance deadline
Texas Medical Privacy Law: Rx Industry Seeks Amendment Before Sept. 1
The pharmaceutical industry is attempting to amend a Texas medical privacy law that would restrict drug companies' use of patient information before the law's Sept. 1 compliance deadline
Privacy Bill In California Could Preview Fights On “Opt Out,” State Preemption
Pharmaceutical companies and their agents would be required to allow patients to receive drugs even if patients do not consent to disclosure of their medical information under legislation pending in the California state assembly